Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Targeted Therapies in Non-Small Cell Lung Cancer

Research output: Contribution to journalLetterContributedpeer-review

Contributors

  • Maximilian Webendoerfer - , University Hospital Essen (Author)
  • Sophie Heinzen - , University Hospital Frankfurt (Author)
  • Christine Sibbert - , Ulm University Medical Center (Author)
  • Marie-Elisabeth Leßmann - , Department of Internal Medicine I (Author)
  • Cornelia Kropf-Sanchen - , Ulm University Medical Center, DKFZ Hector Cancer Institute at the University Medical Center Mannheim (Author)
  • Michael Thomas - , University Hospital Heidelberg, National Center for Tumor Diseases (NCT) Heidelberg, Translational Lung Research Center Heidelberg (TLRC) - DZL Heidelberg (Author)
  • Amanda Tufman - , Hospital of the Ludwig-Maximilians-University (LMU) Munich, German Center for Lung Research (DZL) - Partner site Munich (Author)
  • Annalen Bleckmann - , University Hospital Münster (Author)
  • Marcel Wiesweg - , University Hospital Essen (Author)
  • Frank Griesinger - , Klinikum Oldenburg - University Medicine (Author)
  • Lea Reitnauer - , University Hospital Münster (Author)
  • Tobias Raphael Overbeck - , University Medical Center Göttingen (Author)

Details

Original languageEnglish
Pages (from-to)142–147
Number of pages7
JournalOncology research and treatment
Volume48
Issue number3
Early online date3 Dec 2024
Publication statusPublished - Mar 2025
Peer-reviewedYes

External IDs

ORCID /0009-0005-7029-0028/work/175220887
unpaywall 10.1159/000542957
Scopus 85214830694

Keywords

Sustainable Development Goals

ASJC Scopus subject areas

Keywords

  • AIO, ESMO, Lung cancer, NSCLC, Non-small cell lung cancer, Targeted therapy, Thoracic oncology